These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
221 related items for PubMed ID: 15589470
1. Primary immunosuppression with tacrolimus after liver transplantation: 12-years follow-up. Jonas S, Neuhaus R, Junge G, Klupp J, Theruvat T, Langrehr JM, Settmacher U, Neuhaus P. Int Immunopharmacol; 2005 Jan; 5(1):125-8. PubMed ID: 15589470 [Abstract] [Full Text] [Related]
2. Rejection episodes after liver transplantation during primary immunosuppression with FK506 or a cyclosporine-based regimen: a controlled, prospective, randomized trial. Jonas S, Kling N, Bechstein WO, Blumhardt G, Lohmann R, Lobeck H, Neuhaus P. Clin Transplant; 1995 Oct; 9(5):406-14. PubMed ID: 8541635 [Abstract] [Full Text] [Related]
4. Adult liver transplantation and steroid-azathioprine withdrawal in cyclosporine (Sandimmun)-based immunosuppression - 5 year results of a prospective study. Lerut JP, Ciccarelli O, Mauel E, Gheerardhyn R, Talpe S, Sempoux C, Laterre PF, Roggen FM, Van Leeuw V, Otte JB, Gianello P. Transpl Int; 2001 Dec; 14(6):420-8. PubMed ID: 11793040 [Abstract] [Full Text] [Related]
5. Early steroid withdrawal after liver transplantation: the Canadian tacrolimus versus microemulsion cyclosporin A trial: 1-year follow-up. Greig P, Lilly L, Scudamore C, Erb S, Yoshida E, Kneteman N, Bain V, Ghent C, Marotta P, Grant D, Wall W, Tchervenkov J, Barkun J, Roy A, Marleau D, McAlister V, Peltekian K. Liver Transpl; 2003 Jun; 9(6):587-95. PubMed ID: 12783400 [Abstract] [Full Text] [Related]
7. Primary immunosuppression with tacrolimus in kidney transplantation: three-year follow-up in a single center. Kim HC, Hwang EA, Han SY, Park SB, Kim HT, Cho WH. Transplant Proc; 2004 Sep; 36(7):2082-3. PubMed ID: 15518753 [Abstract] [Full Text] [Related]
8. A randomized, placebo-controlled trial with anti-interleukin-2 receptor antibody for immunosuppressive induction therapy after liver transplantation. Langrehr JM, Glanemann M, Guckelberger O, Klupp J, Neumann U, Machens C, Lohmann R, Knoop M, Lobeck H, Schlag H, Keck H, Settmacher U, Bechstein WO, Neuhaus PJ. Clin Transplant; 1998 Aug; 12(4):303-12. PubMed ID: 9686324 [Abstract] [Full Text] [Related]
9. Long-term evaluation of cyclosporine and tacrolimus based immunosuppression in pediatric liver transplantation. Hasenbein W, Albani J, Englert C, Spehr A, Grabhorn E, Kemper MJ, Burdelski M, Ganschow R. Pediatr Transplant; 2006 Dec; 10(8):938-42. PubMed ID: 17096762 [Abstract] [Full Text] [Related]
15. Promising early results with immunosuppression using rabbit anti-thymocyte globulin and steroids with delayed introduction of tacrolimus in adult liver transplant recipients. Tector AJ, Fridell JA, Mangus RS, Shah A, Milgrom M, Kwo P, Chalasani N, Yoo H, Rouch D, Liangpunsakul S, Herring S, Lumeng L. Liver Transpl; 2004 Mar; 10(3):404-7. PubMed ID: 15004768 [Abstract] [Full Text] [Related]
19. Ten years of treatment with tacrolimus is related to an excellent renal function, allowing monotherapy in a large proportion of cases: unicentric results of the tacrolimus versus cyclosporine A European Multicentric Study in kidney transplant patients. Morales JM, Andrés A, Dominguez-Gil B, Arriola M, Gutiérrez MJ, Hernández E, Ortuño T, Praga M. Transplant Proc; 2005 Nov; 37(9):3738-42. PubMed ID: 16386523 [Abstract] [Full Text] [Related]
20. Induction therapy including antithymocyte globulin induces marked alterations in T lymphocyte subpopulations after liver transplantation: results of a long-term study. Oertel M, Sack U, Kohlhaw K, Lehmann I, Emmrich F, Berr F, Hauss J, Schwarz R. Transpl Int; 2002 Oct; 15(9-10):463-71. PubMed ID: 12389078 [Abstract] [Full Text] [Related] Page: [Next] [New Search]